Table 3.
Distribution of concomitant drug treatment
| Therapy | Yes | No | Tinnitus Yes | Tinnitus No | P-value |
|---|---|---|---|---|---|
| ACE-inhibitors | 53.24 | 46.76 | 51.50 | 53.79 | NS |
| ARBs | 52.92 | 47.08 | 63.95 | 49.38 | .001 |
| Antiplatelets | 86.22 | 13.78 | 84.55 | 86.76 | NS |
| NSAIDs | 22.38 | 77.62 | 37.07 | 17.68 | .001 |
| Ca antagonist | 19.83 | 80.17 | 16.81 | 18.89 | NS |
| Warfarin | 19.24 | 80.76 | 20.35 | 56.55 | NS |
| Diuretics | 58.77 | 41.23 | 65.67 | 53.9 | .014 |
| Alfa-blockers | 5.45 | 94.5 | 5.60 | 4.66 | NS |
| Beta-blockers | 42.48 | 57.52 | 75.06 | 78.2 | NS |
| Statins | 5.38 | 94.62 | 7.82 | 4.63 | NS |
| Nitroderivates | 25.45 | 74.55 | 22.84 | 26.28 | NS |
| Antialdosterone drugs | 14.03 | 85.97 | 16.81 | 13.14 | NS |
Abbreviations: ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blocker; Ca, calcium; NS, not significant; NSAIDs, nonsteroidal anti-inflammatory drugs.